1.Momen S, Al-Niami F, Barlow R, Mallipeddi R. The use of lasers in cutaneous sarcoid: Is there a role? J Cosmet Laser Ther. 2016; 1-10

 

2.Barlow RJ, Mallipeddi R, Sheth N. Is Mohs micrographic surgery more effective than wide local excision for treatment of dermatofibrosarcoma protuberans in reducing risk of local recurrence? A critically appraised topic. Br J Dermatol 2013;168(1):229-30

 

3. Hassan H, Lowe NJ, Barlow R, Harris D. Four methods of evaluation of facial erythema and pigment treated with intense ulsed light or cream. J Cos Laser Ther 2012;14:200-6

 

4.Morris S, Barlow R, Selva D, Malhotra R. Allergic contact dermatitis: a case series and review for the ophthalmologist. Br J Opthalmol 2011; 95(7): 903-8

 

5.Tan WP, Barlow RJ, Robson A, Kurwa HA, McKenna J, Mallipeddi R. Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections. Br J Dermatol 2011; 164(2):363-6

 

6.Gleeson CM, Lucas S, Langrish CJ, Barlow RJ. Acute fatal fat embolism after autologous fat transfer in a patient with lupus profundus. Dermatol Surg 2011; 37(1): 111-5

 

7.Palamaras I, McKenna JD, Robson R, Barlow RJ. Microcystic adnexal carcinoma: a case series treated with Mohs’ micrographic surgery and identification of patients in whom paraffin sections may be preferable. Dermatol Surg 2010; 36: 446-52

 

8.Then S-T, Malhotra R, Barlow RJ, Kurwa H et al. Early cure rates with narrow-margin slow-Mohs surgery for the treatment of periocular malignant melanoma. Dermatol Surg 2009; 35: 17-23. 

 

9.Powell MA, Russell Jones R, Barlow RJ. Imiquimod and lentigo maligna – a search for prognostic features in a clinicopathological study with long-term follow-up. Br J Dermatol 2009; 160: 994-8

 

10.Wain EM, Stefanato CM, Barlow RJ. A clinicopathological surprise: amelanotic malignant melanoma. Clin Exp Dermatol 2008; 33(3):365-6.  

 

11.Ee HL, Barlow RJ. Lasers, lights and related technologies: a review of recent journal highlights. Clin Exp Dermatol 2007; 32(1):135-7. 

 

12.Saha M, Barlow R, Bunker CB. Angiokeratoma circumscriptum of the penis. Br J Dermatol. 2006;154(4):775-6. 

 

13.Perrett CM, McGregor J, Barlow RJ, Karran P, Proby C, Harwood CA. Topical methyl aminolaevulinate photodynamic therapy used to treat sebaceous hyperplasia in an organ transplant recipient. Arch Dermatol 2006; 142 (6): 781-2.

 

14.Upjohn E, Barlow R, Robson A. Rudimentary polydactyly in an adult: An unusual presentation to a dermatological surgery unit. Austr J Dermatol 2006; 47: 206-8.

 

15.Willey A, Anderson RR, Azpiazu JL, Bakus AD, Barlow RJ, Dover JS, Garden JM, Kilmer SL, Landa N, Manstein D, Ross EV, Sadick N, Tanghetti EA, Yaghman D, Zelickson B. Complications of laser dermatologic surgery.  Lasers Surg Med 2006; 38: 1-15.

 

16.Mavrrikakis I, Malhotra R, Selva D, Huilgol SC, Barlow RJ. Linear basal cell carcinoma: a distinct clinical entity. J Plast Reconstr Aesth Surg 2006; 59(4) 419-23.

 

17.O’Donoghue N, Barlow RJ. Laser remodelling of nodular nasal lupus pernio . Clin Exp Dermatol 2006; 31 (1): 27-9

 

18.Pathai S, Barlow R, Williams G, Olver J. Mohs’ micrographic surgery for Merkel cell carcinomas of the eyelid. Orbit 2005; 24: 273-5.

 

19.Evans AV, Robson A, Barlow RJ, Kurwa H. Treatment of port wine stains with photodynamic therapy, using pulsed dye laser as a light source, compared with pulsed dye laser alone. Lasers Surg Med 2005; 36: 266-9

 

20.Arora A, Barlow RJ, Williamson JMS, Olver JM. Eyelid sebaceous gland carcinoma treated with  “slow” Mohs’ micrographic surgery. Eye 2004; 18: 854-5.

 

21.Powell AM, Russell-Jones R, Barlow RJ. Topical imiquimod immunotherapy in the management of lentigo maligna. Clin Exp Dermatol 2004; 29: 15-21.

 

22.Exadactylou D, Kurwa HA, Calonje E, Barlow RJ. Treatment of Darier’s disease with photodynamic therapy. Br J Dermatol 2003; 149: 1-5.

 

23.Ang P, Barlow RJ. Non ablative laser resurfacing: a systematic review of the literature. Clin Exp Dermatol 2002; 27: 630-5.

 

24.Huilgol SC, Neill S, Barlow RJ. CO2 laser therapy of vulval lymphangiectasia and lymphangioma cirumscriptum. Dermatol Surg. 2002; 28: 575-7.

 

25.Dacko A, Barlow RJ. On dermatological surgery, registrars and residents. Clin Exp Dermatol. 2002; 27: 90-2.

 

26.Robert DLL, Anstey AV, Barlow RJ and Cox NH on behalf of the British Association of Dermatologists and Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN and Kirkham N on behalf of the Melanoma Study Group. UK Guidelines for the management of cutaneous melanoma. Br J Dermatol. 2002; 146: 7-17.

 

27.Barlow RJ, White CR, Swanson NA. Mohs’ micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br J Dermatol, 2002;  146: 290-4.

 

28.Sciscio A, Stewart K, Grewal J, Mulhern M, Barlow R, Markey A, Joshi N. Periocular Mohs micrographic surgery: Results of a dual-site day-surgery service. Orbit 2001; 20: 209-15

 

29.Yong-Gee SA, Kurwa HA, Barlow RJ. Objective assessment of port wine stains following treatment with the pulsed dye laser. Austral J Dermatol 2001; 243-6.

 

30.Bittencourt RCA, Huilgol SC, Seed PT, Calonje E, Markey AC, Barlow RJ, CO2 laser treatment of angiofibromas: a clinicopathological study with long term follow-up. J Am Acad Dermatol 2001; 45 (5):731-5.

 

31.Ozluer SM, Chuen BY, Barlow RJ, Markey AC. Hypertrophic scar formation following carbon laser ablation of plantar warts in cyclosporin treated patients. Br J Dermatol. 2001; 145: 1005-7.

 

32.Huilgol SC, Poon E, Calonje E, Seed PT, Huilgol RR, Markey AC, Barlow RJ. Scanned continuous wave CO2 laser resurfacing: A closer look at the different scanning modes. Dermatol Surg 2001; 27 (5): 467-70.

 

33.Ozluer S, Barlow RJ. Re-emergence of portwine stains after treatment with the pulsed dye laser. Clin Exp Dermatol 2001; 26: 37-9.

 

34.Ozluer SM, Barlow RJ. Photodynamic therapy for the dermatologist. (CML –Dermatol)

 

35.Acland KM, Calonje E, Seed PT, Barlow RJ. A clinical and histological comparison of electrosurgical and CO2 laser peels. J Am Acad Dermatol 2001; 44 (3): 492-6.

 

36.Barlow RJ. Role of Mohs’ surgery in the management of skin cancer. CME Bull Dermatol 2001; 2 (3): 79-82.

 

37.Kurwa HA, Barlow RJ, Neill S. Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy. Br J Dermatol 2000; 143: 1040-2.

 

38.Acland KM, Barlow RJ. Lasers for the dermatologist. Br J Dermatol 2000; 143: 244-55.

 

39.Grattan CEH, O’Donnell BFO, Francis DM, Niimi N, Barlow RJ, Seed PT, Kobza Black A, Greaves MW. Randomized double-blind study of cyclosporin in chronic “idiopathic” urticaria. Br J Dermatol 2000; 143: 365-72

 

40.Kurwa HA, Yong-Gee SA, Seed PT, Markey AC, Barlow RJ. A randomised comparison of photodynamic therapy with topical 5 fluorouracil in the treatment of actinickeratoses. J Am Acad Dermatol; 1999; 41 (3): 414-8.

 

41.O’Donnell BF, O’Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ, Kobza Black A, Welsh KI, Greaves MW. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol; 1999; 140: 853-8.

 

42.Kurwa HA, Barlow RJ. The role of photodynamic therapy in dermatology. Clinic Exp Dermatol; 1999; 24: 143-8.

 

43.O’Donnell BF, Barr RM, Kobza Black A, Francis DM, Kermani F, Niimi N, Barlow RJ, Winkelmann RK, Greaves MW. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol; 1998; 138: 101-6.

 

44.Barlow RJ, Swanson NA. The nasofacial interpolated flap in reconstruction of the nasal ala. J Am Acad Dermatol. 1997; 36: 965-9

 

45.Barlow RJ, Ramnarain N, Smith NP, Mayou B, Markey AC, Walker NPJ. Excision of selected skin tumours using Mohs’ micrographic surgery with horizontal paraffin-embedded sections. Br J Dermatol 1996; 135: 911-7.

 

46.Huilgol S, Barlow RJ, Markey AC. Failure of pulsed dye laser therapy for resistant verrucae  Clin Exp Derm 1996; 21: 93-5.

 

47.Barlow RJ, Walker NPJ, Markey AC.  Treatment of proliferative haemangiomas with the 585 nm pulsed dye laser. Br J Dermatol 1996; 134: 700-4.

 

48.Barlow RJ, Ross E, Macdonald DM, Kobza Black A, Greaves MW. Mast cells and T lymphocytes in chronic urticaria. Cli Exp Allergy 1995; 25: 317-22.

 

49.Barlow RJ, Macdonald DM, Kobza Black A, Greaves MW. The effects of topical corticosteroids in delayed pressure urticaria. Arch Dermatol Res 1995; 287: 285-8.

 

50.Barlow RJ, Ross E, Macdonald DM, Kobza Black A, Greaves MW. Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria. Br J Dermatol 1994; 131: 341-7.

 

51.Barlow RJH, Warburton F, Watson K, Kobza Black A, Greaves MW. The diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol 1993; 29 (6): 954-8.

 

52.Barr RM, Judge MR, Lawlor F, Courtney P, Barlow R, Kobza Black A, Mallet Al, Greaves MW. Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment. Br J Clin Pharmacol 1993; 35: 637-41.

 

53.Barlow RJ, Kobza Black A, Greaves MW. Treatment of severe, chronic urticaria with cyclosporin A. Eur J Dermatol  Venereol 1993; 3: 273-5.

 

54.Barlow RJ, Hubbard H, Greaves MW. Granulomatous cheilitis with associated hepatic and renal involvement. Dermatology short cases from the grand rounds at St John’s Dermatology Centre.  1993; 2(1):9-11.

 

55.Lawlor F, Bird C, Camp RDR, Barlow R, Barr RM, Kobza Black A, Judge MR, Greaves MW. Increased interleukin-6, but reduced inerleukin-1, in delayed pressure urticaria. Br J Dermatol 1993; 128: 500-3.

 

56.Botto M, Fong KY, So AY, Barlow R, Routier R, Morley BJ, Walport MJ. Homozygous hereditary C3 deficiency due to a partial gene deletion. Proc Natl Acad Sci USA 1992; 89: 4957-61.

 

57.Grattan CEH, Francis DM, Slater NGP, Barlow RJ, Greaves MW. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992; 339: 1078-80.

 

58.Barlow RJ, Greaves MW. Warfarin in the treatment of chronic urticaria/angioedema. Br J Dermatol 1992; 126: 415-6. (letter)

 

59.Barlow RJ, Schulz EJ. Chronic subcorneal pustulosis with vasculitis: a variant of generalised pustular psoriasis in black South Africans. Br J Dermatol 1991; 124: 470-474.

 

60.Heyl T, Barlow RJ. Thallium poisoning: a dermatological perspective. Br J Dermatol 1989; 121: 787 – 792.

 

61.Barlow RJ, Schulz EJ. Lisinopril induced vasculitis. Clin Exp Dermatol 1988; 13: 117-120.

 

62.Barlow RJ, Heyl T, Simson IW, Schulz EJ. Malignant atrophic papulosis (Degos disease) – Diffuse involvement of brain and bowel in an African patient. Br J Dermatol 1988; 118: 117 – 123

 

63.Barlow RJ, Schulz EJ. Necrotising folliculitis in AIDS-related-complex. Br  J Dermatol 1987; 116: 581 –584.

 

64.Barlow RJ, Connell MA, Milne FJ. A study of 48 hour faecal and urinary electrolyte excretion in normotensive black and white South African males. J Hypertension 1986; 4: 197-200.

 

65.Barlow RJ, Connell MA, Levendig BJ, Gear JGS, Milne FJ. A comparative study of urinary sodium and potassium excretion in normotensive urban black and white South African males. S Afr Med J 1982; 62: 939-41.